Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2019

Etebari M, Navari M, Agostinelli C, Visani A, Peron C, Iqbal J, et al. Transcriptional Analysis of Lennert Lymphoma Reveals a Unique Profile and Identifies Novel Therapeutic Targets. Front Genet. 2019;10:780.

Greenlee H, Shi Z, Hibshoosh H, Giri DD, Ahmed A, Williams S, et al. Obesity-associated Breast Inflammation among Hispanic/Latina Breast Cancer Patients. Cancer Prev Res (Phila). 2019;12(1):21-30.

Cushing MM, Pagano MB, Jacobson J, Schwartz J, Grossman BJ, Kleinman S, et al. Pathogen reduced plasma products: a clinical practice scientific review from the AABB. Transfusion. 2019;59(9):2974-2988.

Weinberg OK, Hasserjian RP, Baraban E, Ok CY, Geyer JT, Philip JK, et al. Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group. Mod Pathol. 2019;32(9):1373-1385.

Ouseph MM, Krigman H, He M. - An Uncommon but Noteworthy Cause of Intrauterine Fetal Demise and Acute Necrotizing Funisitis. Fetal Pediatr Pathol. 2019;38(4):352-358.

Chavda KD, Westblade LF, Satlin MJ, Hemmert AC, Castanheira M, Jenkins SG, et al. First Report of - and -Coharboring Species Isolated from a Pediatric Patient. mSphere. 2019;4(5).

Ware AD, Murdock T, Voltaggio L, Windon AL, Troncoso JC, Hruban RH, et al. The "Race" Toward Diversity, Inclusion, and Equity in Pathology: The Johns Hopkins Experience. Acad Pathol. 2019;6:2374289519873104.

Nouizi F, Kwong TC, Ruiz J, Cho J, Chan Y-, Ikemura K, et al. A thermo-sensitive fluorescent agent based method for excitation light leakage rejection for fluorescence molecular tomography. Phys Med Biol. 2019;64(3):035007.

Zadra G, Loda M. When fat goes down, prostate cancer is on the ropes. Mol Cell Oncol. 2019;6(3):1595308.

Tetzlaff MT, Curry JL, Ning J, Sagiv O, Kandl TL, Peng B, et al. Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations. Clin Cancer Res. 2019;25(4):1280-1290.